According to Cocrystal Pharma
's latest financial reports the company has a price-to-book ratio of 0.5953.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.6641 | 65.48% |
2022-12-31 | 0.4013 | -50.88% |
2021-12-31 | 0.8170 | -54% |
2020-12-31 | 1.78 | 162.14% |
2019-12-31 | 0.6775 | -57.95% |
2018-12-31 | 1.61 | 16.6% |
2017-12-31 | 1.38 | -48.57% |
2016-12-31 | 2.69 | -27.14% |
2015-12-31 | 3.69 | -52.33% |
2014-12-31 | 7.74 | -193.7% |
2013-12-31 | -8.26 | -85.6% |
2012-12-31 | -57.3 | -36.68% |
2011-12-31 | -90.5 | |
2010-12-31 | N/A | |
2009-12-31 | N/A | -100% |
2008-12-31 | 39.9 | |
2007-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.14 | 764.18% | ๐บ๐ธ USA |
Merck MRK | 8.76 | 1,371.16% | ๐บ๐ธ USA |
Nature's Sunshine Products NATR | 2.33 | 291.44% | ๐บ๐ธ USA |
USANA USNA | 1.66 | 179.39% | ๐บ๐ธ USA |